Infectious Diseases
Laboratory Science
The Department of Epidemiology of Microbial Diseases has an established record of public health discovery through laboratory science. In the school’s first century, YSPH led the fight against poliomyelitis, housed the Arbovirus Research Unit which moved from the Rockefeller Foundation to Yale in 1964 (and was home to Nobel prize-winning scientist Max Theiler and other prominent scientists), as well as the WHO serum bank. Today, Yale is home to several modern laboratories that address vector-borne diseases transmitted by tsetse flies, ticks, mosquitoes and sand flies. In addition, our scientists are pursuing solutions to respiratory ailments, antibiotic resistance, diagnostic testing, vaccine development and infections related to STIs and intravenous drug use.
Recent Publications
- PLos One
The Potential Impact of Triage Protocols on Racial Disparities in Clinical Outcomes Among COVID-positive Patients in a Large Academic Healthcare System - Cell
COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants - Annals of Internal Medicine
Population Immunity Against COVID-19 in the United States - BMC Public Health
Influenza Vaccination Should have No Border: Cost-effectiveness of Cross-border Subsidy - JAMA
Confronting the Delta Variant of SARS-CoV-2, Summer 2021 - Annals of Internal Medicine
Assessing COVID-19 Prevention Strategies to Permit the Safe Opening of Residential Colleges in Fall 2021 - Lancet Regional Health. Americas
Repeat Positive SARS-CoV-2 RNA Testing in Nursing Home Residents During the Initial 9 Months of the COVID-19 Pandemic: an Observational Retrospective Analysis - Lancet Regional Health. Americas
The Unrecognized Death Toll of COVID-19 in the United States - JAMA
Potential Benefits of Expanded COVID-19 Surveillance in the US